Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUSStandard

VABOMERE

MEROPENEM; VABORBACTAM

Standard Dose
1GM/VIAL;1GM/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview VABOMERE is listed in Drugs@FDA under application 209776 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient MEROPENEM; VABORBACTAM Form and strength POWDER;INTRAVENOUS - 1GM/VIAL;1GM/VIAL Sponsor REMPEX Submission history Latest submission status date: 2026-02-20 00:00:00.

Structured Monograph

Clinical summary

Approval overview VABOMERE is listed in Drugs@FDA under application 209776 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient MEROPENEM; VABORBACTAM Form and strength POWDER;INTRAVENOUS - 1GM/VIAL;1GM/VIAL Sponsor REMPEX Submission history Latest submission status date: 2026-02-20 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
VABOMERE (MEROPENEM; VABORBACTAM) | Drug Monograph | MedicHelpline